Alkahest
AcquiredAlkahest is a biotech company in San Carlos, United States, founded in 2014. It has raised $37.5M across 1 round, most recently a $37.5M Series A in March 2015.
Therapies Born from the Science of Plasma
- Headquarters
- San Carlos, California
- Employees
- 51–200
- Founded
- 2014
- Website
- alkahest.com
- Total Funding
- $37.5M
- Last Round
- $37.5M Series AMar 2015
- Rounds
- 1
- Acquisition Date
- Sep 2020
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Alkahest, a Grifols subsidiary, researches plasma biology to inform potential therapies and solutions for patients. It combines artificial intelligence and integrative analysis of multiomics and real-world data with plasma-protein expertise. The company studies how changes in the plasma proteome relate to disease and uses a large repository of plasma samples and health data to pursue biomarkers and personalized medicine.
Summary
It lists 51–200 employees. It has raised $37.5M in total across 1 round, most recently a $37.5M Series A round in Mar 2015. Investors include Grifols.
Funding & Exit History
Sep 2020
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alkahest"><img src="https://indexed.vc/api/badge/company/alkahest" alt="Alkahest on Indexed.vc" width="260" height="76" /></a>